CD276 and neoplasm: Ex vivo IVIS imaging of tumor and major organs, including the heart, liver, spleen, lungs, kidneys and brain, further confirmed the specific targeting of CD276 mAb to TNBC, with no detectable off-targeting accumulation in normal organs.